Answers are grounded in this paper and cite their sources.
These results indicate that bosentan-induced liver injury is mediated, at least in part, by inhibition of Bsep/BSEP-causing intracellular accumulation of cytotoxic bile salts and bile salt induced liver cell damage. The data further emphasize the pathophysiologic importance of drug-Bsep interactions in acquired forms of cholestatic liver injury.
No takes yet. Share an insight, caveat, or question.
Karin Fattinger (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: